Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds


September 16, 2026

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission


September 10, 2026

Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference


September 9, 2026

Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity’s 46th Annual Growth Conference


August 5, 2026

Cardiol Therapeutics’ Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association


July 14, 2026

Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit


July 9, 2026

Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders


June 25, 2026

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT


June 23, 2026

Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ


May 14, 2026

2026 Cardiol Therapeutics. All right reserved.